A frame shift mutation in the DNA-binding domain of the androgen receptor gene associated with complete androgen insensitivity, persistent müllerian structures, and germ cell tumors in dysgenetic gonads

Fertil Steril. 1999 Jul;72(1):170-3. doi: 10.1016/s0015-0282(99)00169-7.

Abstract

Objective: To describe the molecular, cytogenetic, immunohistochemical, and endocrinologic characteristics of a young 46,XY female with persistent müllerian structures and germ cell tumors in dysgenetic gonads.

Design: Descriptive case study.

Setting: Mackay Memorial Hospital and National Yang-Ming University, Taipei, Taiwan.

Patient(s): A 22-year-old 46,XY female with persistent müllerian structures, a low level of serum testosterone, and no apparent adnexal masses.

Intervention(s): Laparoscopic removal of the dysgenetic gonads.

Main outcome measure(s): Detection of an androgen receptor gene mutation by a semiautomated DNA sequencer, of the chromosomal complement by cytogenetic examination, of placental alkaline phosphatase activity by immunohistochemical analysis, and of neoplasms in dysgenetic gonads by histologic studies.

Result(s): A unilateral gonadoblastoma and a contralateral gonadoblastoma associated with a dysgerminoma were found in the excised gonads. The tumors had a 46,XY complement. Placental alkaline phosphatase was present in the tumor cells. A frameshift mutation in the DNA-binding domain of the androgen receptor gene was detected in the patient's blood and the tumor tissues. A five-nucleotide "AGGAA" deletion at codons 608 and 609 of the androgen receptor gene resulted in a missing arginine and lysine as well as a frameshift that introduced a stop codon 12 amino acid downstream from the mutation.

Conclusion(s): Molecular genetic analysis of the androgen receptor gene aids in the rapid diagnosis of complete androgen insensitivity irrespective of atypical clinical phenotypes and endocrinologic parameters.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Androgen-Insensitivity Syndrome / complications
  • Androgen-Insensitivity Syndrome / genetics*
  • Binding Sites / genetics
  • DNA Mutational Analysis
  • DNA-Binding Proteins / genetics
  • Dysgerminoma / complications
  • Dysgerminoma / genetics*
  • Female
  • Frameshift Mutation
  • Gonadal Dysgenesis / complications
  • Gonadal Dysgenesis / genetics*
  • Humans
  • Karyotyping
  • Male
  • Mullerian Ducts / abnormalities*
  • Neoplasms, Germ Cell and Embryonal / complications
  • Neoplasms, Germ Cell and Embryonal / genetics*
  • Receptors, Androgen / genetics*

Substances

  • DNA-Binding Proteins
  • Receptors, Androgen